Search Results 251-260 of 18478 for prednisone

1. Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study - Mayo Clinic

   daily prednisone equivalents are permitted in the absence of active autoimmune disease - History of severe allergic, anaphylactic or other hypersensitivity ...

2. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

   Subjects with a requirement for systemic steroids receiving >10 mg/day of prednisone (or equivalent) for the 2 weeks preceding start of study treatment.

3. Examining the efficacy of recombinant zoster vaccination in patients with IBD - Mayo Clinic

   "For example, prednisone, thiopurines, anti-TNFs and JAK inhibitors are associated with a significantly increased risk of shingles in patients with IBD." Dr ...

4. Drugs and Supplements that Start with T - Mayo Clinic

   Teva-predniSONE. Also known as. Prednisone (oral route). Teva-Tecnal C1/2. Also known as. Butalbital, aspirin, caffeine, and codeine (oral route). Teva-Tecnal ...

5. A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Steroids administered post-radiation therapy tapered to ≤ 10 mg prednisone (or equivalent) before starting study treatment. Active, known, or suspected ...

6. Treatment of Moderate to Severe Refractory Crohn's Disease - Mayo Clinic

   * 220). 5. Subject on treatment with corticosteroids may be included if they meet the following: * prednisone or equivalent dose ≤ 20 mg/day; or * ...

7. Will Patients With Chronic Inflammatory Condition Need Repeat Cortisone Injections? - Mayo Clinic News Network

   March 23, 2012. Dear Mayo Clinic: How do cortisone shots work to relieve pain? It appears that they only provide temporary relief and are often given ...

8. Researchers seek to increase use of sirolimus-based immunosuppression for heart transplant recipients - Mayo Clinic

   ... prednisone. However, long-term use of CNIs has been shown to cause chronic kidney disease and may not provide sufficient protection against cardiac ...

9. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

   ... prednisone) in the morning and 10 mg hydrocortisone (or 2.5 mg prednisone) in the evening. Patients with the risk factors for bowel obstruction or bowel ...

10. Non-Hodgkin Lymphoma Clinical Trials - Mayo Clinic Research

    ... prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for ...